Metraipolis › archive › dc_cc3d9cd2c18e

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for… — Europe PMC PMID:42396165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42396165
DOI
10.3389/fmed.2026.1843800
License (as archived)
solo-consultazione
Archived
2026-10-19T08:31:43.864Z
SHA-256 of the archived text
30d0c5affb70fdbd0203cec246a74bf5db508025a55f9649e4699fec5cb7000c
Stable URL of this page
https://metraipolis.com/documento/dc_cc3d9cd2c18e

How to cite

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for… — Europe PMC PMID:42396165 — Europe PMC (en), https://europepmc.org/article/MED/42396165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc3d9cd2c18e (Metraipolis archive dc_cc3d9cd2c18e, sha256 30d0c5affb70fdbd0203cec246a74bf5db508025a55f9649e4699fec5cb7000c)
BibTeX
@misc{dccc3d9cd2c18e,
  title = {Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for… — Europe PMC PMID:42396165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42396165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc3d9cd2c18e; sha256 30d0c5affb70fdbd0203cec246a74bf5db508025a55f9649e4699fec5cb7000c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42396165. Agents can read the archived copy with the MCP tool read_document.